4 min
Novartis wins rare cancer pediatric indication, BMS layoffs, McKinsey under fire [The good, the bad, the ugly] Off Script: A Pharma Manufacturing Podcast
-
- Næringslivsnyheter
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week:
The good — Novartis wins rare cancer pediatric indication for LutatheraThe bad — BMS unveils cost-saving initiative, layoffsThe ugly — McKinsey under fire for alleged role in opioid crisis
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week:
The good — Novartis wins rare cancer pediatric indication for LutatheraThe bad — BMS unveils cost-saving initiative, layoffsThe ugly — McKinsey under fire for alleged role in opioid crisis
4 min